Bristol-Myers Squibb

Bristol-Myers' Opdivo fails late-stage brain cancer trial
Yahoo/Reuters
Thu, 05/9/19 - 10:45 am
Bristol-Myers Squibb
Opdivo
clinical trials
glioblastoma multiforme
Don't worry about our $19B bond issue, BMS says. With Celgene, we'll have the cash to pay it off
Fierce Pharma
Wed, 05/8/19 - 05:18 pm
M&A
Bristol-Myers Squibb
Celgene
Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming
Motley Fool
Thu, 04/25/19 - 07:14 pm
earnings
Bristol-Myers Squibb
Celgene
M&A
BMS' head and neck cancer hopes take a hit with Opdivo-Yervoy trial flop
Fierce Pharma
Thu, 04/25/19 - 12:01 pm
Bristol-Myers Squibb
head and neck cancer
Opdivo
Yervoy
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Tue, 04/23/19 - 12:10 pm
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Mon, 04/22/19 - 10:34 am
Concert Pharmaceuticals
Horizon Pharma
Edwards Lifesciences
Zimmer Biomet
Genfit
Precision Biosciences
Boston Scientific
AbbVie
Alexion
Bristol-Myers Squibb
Baxter
Biomarin
AtriCure
Biogen
Seattle Genetics
IPOs
earnings
Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo/Zacks.com
Thu, 04/18/19 - 10:23 pm
Bristol-Myers Squibb
earnings
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
CNBC
Sat, 04/13/19 - 12:03 pm
M&A
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
The Bristol-Celgene merger is approved. Here are 8 challenges ahead
Stat
Fri, 04/12/19 - 11:54 pm
Bristol-Myers Squibb
Celgene
M&A
Nobel laureate behind Bristol's I-O superstar Opdivo demands a bigger cut
Fierce Pharma
Thu, 04/11/19 - 12:27 pm
Opdivo
Bristol-Myers Squibb
Ono Pharmaceutical
R&D
Bristol-Myers details its failure on Checkmate 451, highlighting a bleak future for their checkpoint combo
Endpoints
Thu, 04/11/19 - 10:17 am
Bristol-Myers Squibb
Opdivo
Yervoy
small cell lung cancer
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
side effects
adverse events
Pfizer
Roche
Takeda
Eli Lilly
Bristol-Myers Squibb
Gilead Sciences
Alexion
Celgene
International Working Group on Signal Detection and Management in Pharmacovigilance
pharmacovigilance
Bristol-Myers' big Celgene buyout showers $187M-plus on Morgan Stanley
Endpoints
Thu, 04/4/19 - 11:07 pm
Bristol-Myers Squibb
Celgene
Morgan Stanley
M&A
Despite research boom, few immunotherapy studies targeting pancreatic cancer
Biopharma Dive
Mon, 04/1/19 - 12:18 pm
pancreatic cancer
cancer immunotherapy
AACR
Bristol-Myers Squibb
Merck
Apexigen
Bristol-Myers Squibb's Opdivo-Yervoy duo provokes response in rare tumors
Fierce Pharma
Sun, 03/31/19 - 03:51 pm
Bristol-Myers Squibb
Opdivo
Yervoy
neuroendocrine tumors
After winning key support for Celgene buyout, Bristol-Myers CEO Caforio emerges as clear likely winner in looming shareholder vote
Endpoints
Sun, 03/31/19 - 03:47 pm
Bristol-Myers Squibb
Celgene
M&A
Starboard
Giovanni Caforio
Bristol-Myers Squibb and Concerto HealthAI Sign Cancer Real World Data Agreement
BioSpace
Fri, 03/29/19 - 10:25 am
Bristol-Myers Squibb
Concerto HealthAI
oncology
real world data
real world evidence
artificial intelligence
Bristol-Myers scores a critical endorsement for its embattled Celgene merger
Stat
Fri, 03/29/19 - 10:17 am
Bristol-Myers Squibb
Celgene
M&A
Bristol-Myers Gets FTC Request for More Information on $74 Billion Celgene Deal
TheStreet.com
Tue, 03/26/19 - 09:44 am
SEC
FTC
M&A
Bristol-Myers Squibb
Celgene

Pages